simulationName;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;R-square;pValue;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd
;5^{th}-Individual ID 4;5^{th}-Individual ID 4;5^{th}-Individual ID 4;5^{th}-Individual ID 4;5^{th}-Individual ID 4;;;95^{th}-Individual ID 15;95^{th}-Individual ID 15;95^{th}-Individual ID 15;95^{th}-Individual ID 15;95^{th}-Individual ID 15
;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape;;;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape
;-0.287526356860244;0.431423382150111;-0.182646670944351;-0.382162357798723;0.913871429836159;;;-0.171553934562249;0.071674360258914;-0.0621566942969406;-0.121569713309922;0.786533551180998
;-0.298717734149557;0.395908667496272;-0.187347404080841;-0.399280893585314;0.893366223579439;;;-0.171748418203597;0.0564701583268522;-0.0629456452350761;-0.125304606175077;0.763438034611014
;-0.27633497957093;0.46693809680395;-0.177945937807861;-0.365043822012132;0.934376636092879;;;-0.171359450920902;0.0868785621909757;-0.0613677433588051;-0.117834820444768;0.809629067750981
;0.999551444705514;0.99799673912919;0.999803834985397;0.999406010925624;0.999850894930944;;;0.999999619316803;0.986846291723396;0.999952279769218;0.9997204991104;0.999744665772844
;4.03247140451443e-06;3.80764393701901e-05;1.16612943090047e-06;6.14517077803778e-06;7.72764039457106e-07;;;9.96860702181144e-11;0.000642811602874042;1.39910041169772e-07;1.98335326427265e-06;1.73175195692921e-06
